2014 Bridging Biomedical Worlds Conference
Turning Obstacles into Opportunities for Stem Cell Therapy
October 13-15, 2014, Beijing
The first Bridging Biomedical Worlds conference, entitled Turning obstacles into opportunities for stem cell therapy, was held in Beijing, China, October 13-15, 2014, and was jointly organized by Fondation IPSEN, AAAS/Science and AAAS/Science Translational Medicine, in association with Fred Gage, Salk Institute for Biological Studies, and Qi Zhou, Institute of Zoology, Chinese Academy of Sciences.
TStem cells hold great promise for treating a variety of human diseases and injuries. Basic and translational stem cell research are among the most competitive fields in the life sciences. In order to promote stem cell research and its translation into clinical therapies as well as to enhance communication and cooperation among stem cell biologists, bioengineers, clinicians, and industry scientists.
The goals of this conference were to highlight exciting on-going studies toward understanding stem cell biology and the translation of basic stem cell research into safe and effective stem cell therapies. The meeting covered a broad range of topics including advances in reprogramming and cell fate determination, large animal models, new tools and techniques, tissue regeneration, and stem cell therapies in the clinic. Panel discussions explored barriers to translation, the risks and ethical controversies associated with moving to the clinic, and ways to implement international guidelines to ensure the safe development of stem cell therapies worldwide.
DE LUCA Michele
Centre for Regenerative Medicine “Stefano Ferrari”, University of Modena and Reggio Emilia, MODENA, ITALY
Key Laboratory of Chemical Genomics, Peking University, SHENZHEN, CHINA
DISCHER Dennis E.
University of Pennsylvania, PHILADELPHIA, USA
FOX Ira J.
Center for Innovative Pediatric Regenerative Therapies, University of Pittsburgh School of Medicine, PITTSBURGH, USA
GAGE Fred H.
Laboratory of Genetics, Salk Institute for Biological Studies, LA JOLLA, USA
Yunnan Key Laboratory of Animal Reproductive Biology, Kunming Institute of Zoology, KUNMING, CHINA
Cell Polarity and Morphogenesis Group, CNRS UMR 7288, MARSEILLE, FRANCE
Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, SHANGHAI, CHINA
McDEVITT Todd C.
Stem Cell Engineering Center, Georgia Institute of Technology, ATLANTA, USA
MUMMERY Christine L.
Department of Anatomy and Embryology, Leiden University Medical Center, LEIDEN, THE NETHERLANDS
Institute of Stem Cell Biology and Regenerative Medicine, Stanford University, STANFORD, USA
Department of Physiology, Keio University School of Medicine, TOKYO, JAPAN
Monash University, Melbourne,Australia
Department of Biosystems Science and Engineering, ETH Zurich, BASEL, SWITZERLAND
WEISSMAN Irving L.
Institute for Stem Cell Biology and Regenerative Medicine Stanford University, STANFORD, USA
College of Animal Sciences, Zhejiang University, HANGZHOU, CHINA
Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, CAMBRIDGE, USA
The State Key Laboratory of Reproductive Biology, Institute of Zoology, BEIJING, CHINA
BetaLogics, Janssen Research & Development, Johnson & Johnson, RARITAN,USA